https://www.has-sante.fr/jcms/p_3578966/fr/briumvi-ublituximab-sclerose-en-plaques 2025 false false false France treatment outcome insurance, health, reimbursement ublituximab adult infusions, intravenous evaluation of the transparency committee multiple sclerosis, relapsing-remitting ublituximab
--- https://www.ema.europa.eu/en/medicines/human/EPAR/briumvi 2023 false false false United Kingdom French English treatment outcome syndication feed summary of product characteristics package leaflet drug evaluation ublituximab ublituximab ublituximab drug approval europe adult multiple sclerosis, relapsing-remitting infusions, intravenous product surveillance, postmarketing drug interactions pregnancy breast feeding antigens, CD20 drug evaluation, preclinical